Living with Neuroendocrine TumorsPeople with neuroendocrine tumors can lead meaningful, active, productive lives. Learn how you can make the most of every day. Managing NET symptoms Eating right Being active, staying safe Managing emotions Finding support See how others live with NETs made one or more lifestyle changes due to NETs2 0 % report general fatigue/muscle weakness2 0 % experienced diarrhea2 0 % The latest in NETRF News CAR T-Cell Therapy for Neuroendocrine Cancer, Now in Clinical Trial, Receives FDA FAST TRACK Designation (Boston, MA): The Neuroendocrine Tumor Research Foundation (NETRF) is proud to join Chimeric Therapeutics in New ALT Biomarker Enhances Prognostic Accuracy in Pancreatic Neuroendocrine Tumors Pancreatic neuroendocrine tumors (PanNETs) can have a variety of behaviors. Some stay slow-growing for years, Belzutifan Approved for Pheo Para In a breakthrough for those with advanced pheochromocytoma and paraganglioma (Pheo/Para), the U.S. Food and Browse our Youtube Channel Video Library Subscribe to NETRF Podcast Attend a NET patient conference Patient Events Find support groups in your area Check out patient advocacy groups 2Singh S, Granberg D, Wolin E, et al. Patient-reported burden of a neuroendocrine tumor (NET) diagnosis: results from the first global survey of patients with NETs. J Glob Oncol. 2016;2(1):43-53.
CAR T-Cell Therapy for Neuroendocrine Cancer, Now in Clinical Trial, Receives FDA FAST TRACK Designation (Boston, MA): The Neuroendocrine Tumor Research Foundation (NETRF) is proud to join Chimeric Therapeutics in
New ALT Biomarker Enhances Prognostic Accuracy in Pancreatic Neuroendocrine Tumors Pancreatic neuroendocrine tumors (PanNETs) can have a variety of behaviors. Some stay slow-growing for years,
Belzutifan Approved for Pheo Para In a breakthrough for those with advanced pheochromocytoma and paraganglioma (Pheo/Para), the U.S. Food and